Inventor · disambiguated record
Arnaud Marchand
Also filed as: MARCHAND ARNAUD · MARCHAND ARNAUD DIDIER M · MARCHAND ARNAUD DIDIER MARIE
44 granted patents·22 pending applications·208 citations·filing 2004–2025
97Inventor score
Files withUNIV LEUVEN KATH22JANSSEN PHARMACEUTICALS INC21ALIGOS THERAPEUTICS INC8GRIFFIOEN GERARD3CHALTIN PATRICK2
Top patents by PatentIndex Score
66 records- 0197US11851422B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·8 cites·61 claims
- 0295US10919854B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·28 claims
- 0395US9944598B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 17, 2018·21 cites·17 claims
- 0494US11827602B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 28, 2023·2 cites·11 claims
- 0594US10029984B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·21 cites·5 claims
- 0693US10117850B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesUNIV LEUVEN KATH·Filed 2016·Granted Nov 6, 2018·21 cites·19 claims
- 0792US11952365B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·2 cites·18 claims
- 0892US10206902B2Mono- or di-substituted indoles as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Feb 19, 2019·14 cites·9 claims
- 0992US7501513B2Immunosuppressive effects of pteridine derivatives4 AZA BIOSCIENCE NV·Filed 2004·Granted Mar 10, 2009·28 cites·6 claims
- 1091US10696632B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 30, 2020·3 cites·13 claims
- 1190US12209081B2Heterocycle derivatives for treating TRPM3 mediated disordersUNIV LEUVEN KATH·Filed 2024·Granted Jan 28, 2025·3 cites·9 claims
- 1289US12065428B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·1 cites·23 claims
- 1389US11180450B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 1489US10689340B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 23, 2020·4 cites·8 claims
- 1588US12172959B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·27 claims
- 1688US2025230127A1Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1787US8889711B2Pyrazolopyridine derivatives as anticancer agentBEDJEGUELAL KARIM·Filed 2010·Granted Nov 18, 2014·51 cites·19 claims
- 1882US12252481B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·0 cites·23 claims
- 1980US9266832B2Compounds for the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2011·Granted Feb 23, 2016·8 cites·14 claims
- 2078US8906906B2Viral replication inhibitorsCHALTIN PATRICK·Filed 2010·Granted Dec 9, 2014·4 cites·14 claims
- 2175US8618138B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2010·Granted Dec 31, 2013·3 cites·18 claims
- 2274US11795149B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Oct 24, 2023·0 cites·13 claims
- 2374US10550123B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2012·Granted Feb 4, 2020·3 cites·17 claims
- 2472US8785638B2Thieno [2, 3-B] pyridine derivatives as viral replication inhibitorsBARDIOT DOROTHÉE·Filed 2010·Granted Jul 22, 2014·4 cites·9 claims
- 2569US11702387B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 18, 2023·0 cites·14 claims
- 2669US9434722B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesUNIV LEUVEN KATH·Filed 2013·Granted Sep 6, 2016·1 cites·20 claims
- 2769US2025243187A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2868US12012411B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2021·Granted Jun 18, 2024·0 cites·18 claims
- 2967US11939324B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2022·Granted Mar 26, 2024·0 cites·12 claims
- 3067US9132129B2Antiviral compoundsCHALTIN PATRICK·Filed 2011·Granted Sep 15, 2015·1 cites·13 claims
- 3166US2024199647A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3266US2024182444A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3365US12404266B2Heterocycle derivatives for treating TRPM3 mediated disordersUNIV LEUVEN KATH·Filed 2021·Granted Sep 2, 2025·0 cites·13 claims
- 3465US2024018126A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3562US11407715B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 9, 2022·0 cites·21 claims
- 3660US11053196B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jul 6, 2021·0 cites·25 claims
- 3759US11083707B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 10, 2021·0 cites·15 claims
- 3858US10633378B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Granted Apr 28, 2020·0 cites·5 claims
- 3958US2019054068A1Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative DiseasesUNIV LEUVEN KATH·Filed 2018·Application pending·0 cites
- 4058US2025376469A1Indolizine derivatives for treating trpm3-mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4158US2025376468A1PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERSUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4258US2025346605A1New derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4358US2025346569A1New derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4457US11279704B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2019·Granted Mar 22, 2022·0 cites·53 claims
- 4557US2025376461A1Indazole derivatives for treating trpm3-mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4657US2025346583A1New derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4757US2025320189A1New derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 4856US11566025B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2020·Granted Jan 31, 2023·0 cites·18 claims
- 4956US2015051195A1Novel viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Application pending·0 cites
- 5052US10646469B2Substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted May 12, 2020·0 cites·7 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Arnaud Marchand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →